Figure 2From: 18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin) Mean SUVmax, PSA and ALP changes. Mean SUVmax, PSA and ALP changes at 6 and 12 weeks as a percentage of baseline levels in the five subjects (A to E).Back to article page